|
|
Volumn 12, Issue 10 I, 1999, Pages 1000-1008
|
|
Double-blind randomized placebo-controlled study of transdermal estrogen replacement therapy on hypertensive postmenopausal women
a
|
|
Author keywords
Cardiovascular risk factors; Echocardiography; Estrogen replacement therapy; Hypertension; Left ventricular mass
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ESTRADIOL;
ESTROGEN;
FIBRINOGEN;
GLUCOSE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
NORETHISTERONE ACETATE;
TRIACYLGLYCEROL;
ADULT;
ANTIHYPERTENSIVE THERAPY;
ARTICLE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
ECHOCARDIOGRAPHY;
ESTROGEN THERAPY;
FEMALE;
HEART LEFT VENTRICLE MASS;
HEART VENTRICLE HYPERTROPHY;
HUMAN;
HYPERTENSION;
LIPOPROTEIN BLOOD LEVEL;
MAJOR CLINICAL STUDY;
ORAL DRUG ADMINISTRATION;
POSTMENOPAUSE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TRANSDERMAL DRUG ADMINISTRATION;
ADMINISTRATION, CUTANEOUS;
ADULT;
AGED;
CHOLESTEROL, HDL;
CHOLESTEROL, LDL;
DOUBLE-BLIND METHOD;
ESTRADIOL;
ESTROGEN REPLACEMENT THERAPY;
FEMALE;
HUMANS;
HYPERTENSION;
HYPERTROPHY, LEFT VENTRICULAR;
MIDDLE AGED;
POSTMENOPAUSE;
|
|
EID: 0032705928
PISSN: 08957061
EISSN: None
Source Type: Journal
DOI: 10.1016/S0895-7061(99)00074-6 Document Type: Article |
|
Times cited : (50)
|
|
References (61)
|
